domain semaglutide weight loss maintenance after discontinuation of GLP-1 therapies Semaglutide paired with intensive behavioral

Mode of Action GLP-1 receptors are available in many part of the human body which allow the GLP-1 hormone to exert its functions and effects, reducing body weight, systolic blood pressure, HbA1c and lipid profile ( Figure 3 ) Figure 3: GLP-1 effect on different parts of the body

substantial reductions in fasting blood sugars, waist circumference, and body mass index

Long-acting gut-hormone agonists as a class tend to show tachyphylaxis of the gastric-emptying effect it attenuates with continued dosing even as central appetite suppression persists

It is important to discuss any taste changes with your doctor if you are taking medications

When blood glucose levels return to normal, the incretin effect diminishes, maintaining blood glucose at normal levels with high safety (60, 61)

Weeks 5 to 12 (5mg to 7.5mg): 1 to 3 pounds per week